Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Cross screening panel
Assay data:1 Tested
SummaryRelated BioAssays by Target
Safety47 Scan (DiscoverX - Eurofins)
Adrenergic beta2 Eurofins Panlabs panel
BETA2/HUM Eurofins SafetyScreen44 (BI)
Binding affinity towards human ADRB2 in an in vitro assay with cellular components measured by radioactivity method
Assay data:58 Active, 21 Activity ≤ 1 µM, 952 Tested
Agonist activity at human ADRB2 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method
Assay data:14 Active, 10 Activity ≤ 1 µM, 635 Tested
Inhibition of beta2 adrenergic receptor (unknown origin) upto 10000 nM
Displacement of [3H](-)CGP 12177 from human recombinant beta2 adrenoceptor at 10 uM after 120 mins by scintillation counting analysis relative to control
Assay data:3 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on